Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Community Health
Published in: Journal of Community Health 6/2010

01-12-2010 | Original Paper

Recent Incarceration Linked to Cutaneous Injection-Related Infections Among Active Injection Drug Users in a Canadian Setting

Authors: M.-J. Milloy, Evan Wood, Elisa Lloyd-Smith, Eric Grafstein, Mark Tyndall, Julio Montaner, Thomas Kerr

Published in: Journal of Community Health | Issue 6/2010

Login to get access

Abstract

Cutaneous injection-related infections (CIRI), such as abscesses and cellulitis, are the cause of a substantial burden of morbidity and mortality among injection drug users (IDU). The possible contribution of exposure to correctional environments to CIRI risk has not been fully investigated. Thus, we sought to test the possible relationship between incarceration and CIRI using data from a community-based sample of IDU. Data for these analyses was from the Scientific Evaluation of Supervised Injecting (SEOSI) cohort, linked with administrative records of a local ED in Vancouver, Canada. Using longitudinal analysis we assessed the relationship between the number of ED visits for CIRI care and recent incarceration in a multivariate model including information on possible confounders. Between June 2004 and December 2006, 901 individuals were eligible for our analysis. Of these, 214 (9.6%) visited the ED for CIRI care at least once during the study period. The incidence of ED care for CIRI was 72.9 per 100 person years. In a multivariate model, recent incarceration was associated with a greater number of ED visits for CIRI care (adjusted relative rate = 1.56, 95% confidence interval: 1.31–1.85, P < 0.001). The need for ED treatment for CIRI was common among a sample of local IDU. Exposure to correctional environments was an independent risk factor for visiting the ED for CIRI care, suggesting improvements in infection control in local prisons is urgently needed.
Literature
1.
Binswanger, I. A., Kral, A. H., Bluthenthal, R. N., Rybold, D. J., & Edlin, B. R. (2000). High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clinical Infectious Diseases, 30(3), 579–581.CrossRefPubMed
2.
Burkey, M. D., Wilson, L. E., Moore, R. D., Lucas, G. M., Francis, J., & Gebo, K. A. (2008). The incidence of and risk factors for MRSA bacteraemia in an HIV-infected cohort in the HAART era. HIV Med, 9(10), 858–862.PubMed
3.
Lloyd-Smith, E., Wood, E., Zhang, R., Tyndall, M. W., Montaner, J. S., & Kerr, T. H. (2008). Risk factors for developing a cutaneous injection-related infection among injection drug users: a cohort study. BMC public health, 8(1), 405.CrossRefPubMed
4.
Bassetti, S., & Battegay, M. (2004). Staphylococcus aureus infections in injection drug users: risk factors and prevention strategies. Infection, 32(3), 163–169.CrossRefPubMed
5.
Del Giudice, P. (2004). Cutaneous complications of intravenous drug abuse. British Journal of Dermatology, 150(1), 1–10.CrossRefPubMed
6.
From the Centers for Disease Control and Prevention. (2001). Soft tissue infections among injection drug users—San Francisco, California, 1996–2000. JAMA, 285(21), 2707–2709.CrossRef
7.
Palepu, A., Tyndall, M. W., Leon, H., Muller, J., O’Shaughnessy, M. V., Schechter, M. T., et al. (2001). Hospital utilization and costs in a cohort of injection drug users. CMAJ, 165(4), 415–420.PubMed
8.
Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a state prison—Mississippi, (2000). MMWR Morb Mortal Wkly Rep. 42:919–922.
9.
Methicillin-resistant Staphylococcus aureus infections in correctional facilities—Georgia, California, and Texas, (2001–2003). MMWR Morb Mortal Wkly Rep. 52(41):992–996.
10.
Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections—Los Angeles County, California, (2002–2003). MMWR Morb Mortal Wkly Rep. 52(5):88.
11.
Wootton, S. H., Arnold, K., Hill, H. A., McAllister, S., Ray, M., Kellum, M., et al. (2004). Intervention to reduce the incidence of methicillin-resistant Staphylococcus aureus skin infections in a correctional facility in Georgia. Infection Control and Hospital Epidemiology, 25(5), 402–407.CrossRefPubMed
12.
Aiello, A. E., Lowy, F. D., Wright, L. N., & Larson, E. L. (2006). Meticillin-resistant Staphylococcus aureus among US prisoners and military personnel: review and recommendations for future studies. The Lancet infectious diseases, 6(6), 335–341.CrossRefPubMed
13.
Buavirat, A., Page-Shafer, K., van Griensven, G. J., Mandel, J. S., Evans, J., Chuaratanaphong, J., et al. (2003). Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case-control study. BMJ, 326(7384), 308.CrossRefPubMed
14.
Milloy, M. J., Wood, E., Small, W., Tyndall, M., Lai, C., Montaner, J., et al. (2008). Incarceration experiences in a cohort of active injection drug users. Drug Alcohol Rev, 31, 1–7.
15.
Binswanger, I. A., Stern, M. F., Deyo, R. A., Heagerty, P. J., Cheadle, A., Elmore, J. G., et al. (2007). Release from prison—a high risk of death for former inmates. New England Journal of Medicine, 356(2), 157–165.CrossRefPubMed
16.
Farrell, M., & Marsden, J. (2008). Acute risk of drug-related death among newly released prisoners in England and Wales. Addiction, 103(2), 251–255.CrossRefPubMed
17.
Small, W., Wood, E., Lloyd-Smith, E., Tyndall, M., & Kerr, T. (2008). Accessing care for injection-related infections through a medically supervised injecting facility: a qualitative study. Drug and Alcohol Dependence, 98(1–2), 159–162.CrossRefPubMed
18.
Wood, E., Kerr, T., Lloyd-Smith, E., Buchner, C., Marsh, D. C., Montaner, J. S., et al. (2004). Methodology for evaluating Insite: Canada’s first medically supervised safer injection facility for injection drug users. Harm Reduct J, 1(1), 9.CrossRefPubMed
19.
Kerr, T., Wood, E., Grafstein, E., Ishida, T., Shannon, K., Lai, C., et al. (2005). High rates of primary care and emergency department use among injection drug users in Vancouver. J Public Health (Oxf), 27(1), 62–66.CrossRef
20.
Corneil, T. A., Kuyper, L. M., Shoveller, J., Hogg, R. S., Li, K., Spittal, P. M., et al. (2006). Unstable housing, associated risk behaviour, and increased risk for HIV infection among injection drug users. Health Place, 12(1), 79–85.CrossRefPubMed
21.
Kerr, T., Tyndall, M., Li, K., Montaner, J., & Wood, E. (2005). Safer injection facility use and syringe sharing in injection drug users. Lancet, 366(9482), 316–318.CrossRefPubMed
22.
Wood, E., Tyndall, M. W., Li, K., Lloyd-Smith, E., Small, W., Montaner, J. S., et al. (2005). Do supervised injecting facilities attract higher-risk injection drug users? American Journal of Preventive Medicine, 29(2), 126–130.CrossRefPubMed
23.
Ver Hoef, J. M., & Boveng, P. L. (2008). Quasi-Poisson vs. negative binomial regression: How should we model overdispersed count data? Ecology, 88, 2766–2772.CrossRef
24.
Maldonado, G., & Greenland, S. (1993). Simulation study of confounder-selection strategies. American Journal of Epidemiology, 138(11), 923–936.PubMed
25.
Rothman, K. J., & Greenland, S. (1998). Modern Epidemiology. New York, NY: Lippincott Williams & Wilkins.
26.
Lima, V. D., Geller, J., Bangsberg, D. R., Patterson, T. L., Daniel, M., Kerr, T., et al. (2007). The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART. AIDS, 21(9), 1175–1183.CrossRefPubMed
27.
Craven, D. E., Rixinger, A. I., Goularte, T. A., & McCabe, W. R. (1986). Methicillin-resistant Staphylococcus aureus bacteremia linked to intravenous drug abusers using a “shooting gallery”. American Journal of Medicine, 80(5), 770–776.CrossRefPubMed
28.
Fleisch, F., Zbinden, R., Vanoli, C., & Ruef, C. (2001). Epidemic spread of a single clone of methicillin-resistant Staphylococcus aureus among injection drug users in Zurich, Switzerland. Clinical Infectious Diseases, 32(4), 581–586.CrossRefPubMed
29.
Young, D. M., Harris, H. W., Charlebois, E. D., Chambers, H., Campbell, A., Perdreau-Remington, F., et al. (2004). An epidemic of methicillin-resistant Staphylococcus aureus soft tissue infections among medically underserved patients. Archives of surgery (Chicago, Ill: 1960), 139(9), 947–951. (discussion 51–53).
30.
Gilbert, M., MacDonald, J., Gregson, D., Siushansian, J., Zhang, K., Elsayed, S., et al. (2006). Outbreak in Alberta of community-acquired (USA300) methicillin-resistant Staphylococcus aureus in people with a history of drug use, homelessness or incarceration. Canadian Medical Association Journal, 175(2), 149–154.CrossRefPubMed
31.
Al-Rawahi, G. N., Schreader, A. G., Porter, S. D., Roscoe, D. L., Gustafson, R., & Bryce, E. A. (2008). Methicillin-resistant Staphylococcus aureus nasal carriage among injection drug users: six years later. Journal of Clinical Microbiology, 46(2), 477–479.CrossRefPubMed
32.
Gilbert, M., MacDonald, J., Louie, M., Gregson, D., Zhang, K., Elsayed, S., et al. (2007). Prevalence of USA300 colonization or infection and associated variables during an outbreak of community-associated methicillin-resistant Staphylococcus aureus in a marginalized urban population. The Canadian journal of infectious diseases & medical microbiology, 18(6), 357–362.
33.
Pan, E. S., Diep, B. A., Carleton, H. A., Charlebois, E. D., Sensabaugh, G. F., Haller, B. L., et al. (2003). Increasing prevalence of methicillin-resistant Staphylococcus aureus infection in California jails. Clinical Infectious Diseases, 37(10), 1384–1388.CrossRefPubMed
34.
Binswanger, I. A., Takahashi, T. A., Bradley, K., Dellit, T. H., Benton, K. L., & Merrill, J. O. (2008). Drug users seeking emergency care for soft tissue infection at high risk for subsequent hospitalization and death. Journal of studies on alcohol and drugs, 69(6), 924–932.PubMed
35.
Matas, R. (2008). Inmates to be housed in tents at two B.C. jails. Globe and Mail. 15.
36.
Small, W., Kain, S., Laliberte, N., Schechter, M. T., O’Shaughnessy, M. V., & Spittal, P. M. (2005). Incarceration, addiction and harm reduction: inmates experience injecting drugs in prison. Substance Use and Misuse, 40(6), 831–843.CrossRefPubMed
37.
Small, W., Wood, E., Betteridge, G., Montaner, J., Kerr, T. (2009). The impact of incarceration upon adherence to HIV treatment among HIV-positive injection drug users: A qualitative study. AIDS Care (in press).
38.
Barton-Forbes, M., Hawkes, M., & Moore, D. (2006). Guidelines for the prevention and management of community associated methicillin resistant Staphylococcus aureus (CA-MRSA): a perspective for Canadian health care practitioners. Canadian journal of infectious diseases and medical microbiology, 17, 1B–24B.
39.
Policy brief: Reduction of HIV transmission in prisons. Geneva, Switzerland: World Health Organization/UNAIDS/United Nations Office on Drugs and Crime 2005.
40.
The Dublin Declaration on HIV/AIDS in prisons in Europe and Central Asia. Dublin, Ireland: Irish Penal Reform Trust 2004.
41.
Medical Association. (2004). Improving our health: Why is Canada lagging behind in establishing needle exchange programs in prison?. Toronto, ON: Ontario Medical Association.
42.
Allen, U. D. (2006). Public health implications of MRSA in Canada. CMAJ, 175(2), 161.PubMed
43.
Chambers, H. F. (2005). Community-associated MRSA—resistance and virulence converge. New England Journal of Medicine, 352(14), 1485–1487.CrossRefPubMed
Metadata
Title
Recent Incarceration Linked to Cutaneous Injection-Related Infections Among Active Injection Drug Users in a Canadian Setting
Authors
M.-J. Milloy
Evan Wood
Elisa Lloyd-Smith
Eric Grafstein
Mark Tyndall
Julio Montaner
Thomas Kerr
Publication date
01-12-2010
Publisher
Springer US
Published in
Journal of Community Health / Issue 6/2010
Print ISSN: 0094-5145
Electronic ISSN: 1573-3610
DOI
https://doi.org/10.1007/s10900-010-9269-y

Other articles of this Issue 6/2010

Journal of Community Health 6/2010 Go to the issue

Original Paper

Utilization of the Native American Talking Circle to Teach Incident Command System to Tribal Community Health Representatives

Original paper

The TOTS Community Intervention to Prevent Overweight in American Indian Toddlers Beginning at Birth: A Feasibility and Efficacy Study

Erratum

Erratum to: Injury Prevention for Modern Dancers: A Pilot Study of an Educational Intervention

Original Paper

Further Opportunities for Cost Reduction of Medical Care

Original Paper

Exploring Primary Care Providers’ Interest in Using Patient Navigators to Assist in the Delivery of Tobacco Cessation Treatment to Low Income, Ethnic/Racial Minority Patients

Erratum

Erratum to: Weight Change and Functional Limitations Among Older Adults in North Carolina